0.82
-0.0596(-6.75%)
Currency In USD
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
24
First IPO Date
April 02, 2012
| Name | Title | Pay | Year Born |
| Mr. Gregory Fenton C.F.A. | Chief Executive Officer & Director | 232,836 | N/A |
| Dr. Colin van der Kuur B.Sc., DMIN | Chief Science Officer | 132,538 | N/A |
| Mr. Ryan Shacklock | Senior Vice President of Strategy & Business Development | 132,538 | N/A |
| Ms. Wendy Ford CA, CPA | Chief Financial Officer | 171,941 | N/A |
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.